Literature DB >> 18210108

[Pathology along the liver sinusoids: endothelial and perisinusoidal findings].

H-P Fischer1, U Flucke, H Zhou.   

Abstract

Sinusoidal alterations unrelated to primary hepatocellular damage present without characteristic clinical findings and in these cases the liver biopsy is particularly important. Capillarization of sinusoids is characterized by closing of fenestration, formation of a basal membrane and by the expression of CD34 and is typical for active cirrhosis. In nodular regeneratory hyperplasia, capillarization indicates a local or general disturbance of perfusion. In large regenerative nodules, focal nodular hyperplasia and liver cell adenoma CD34-positive capillaries reflect afferent parts and CD34-negative sinusoids the efferent parts of the parenchymal vascular bed. HCC generally have a completely capillarized CD34-positive vascular bed. Hepatic angiosarcomas and epithelioid hemangioendotheliomas can be easily overseen in liver biopsies, if they spread along the sinusoids without detoriation of the acinar architecture and without significant alteration of the surrounding liver cell plates. Toxic damage of endothelial cells, post-sinusoidal stasis and sinusoidal hyperperfusion are the underlying pathogenetic principles of sinusoidal injury. Rupture and loss of the perisinusoidal reticulin fibres lead to peliosis hepatis. In these cases liver biopsy might disclose occlusion of the terminal liver veins (VOD). Perisinusoidal fibrosis can be caused by intrasinusoidal accumulation of pathologic cells, advanced intrasinusoidal macrophagocytic storage diseases and by activation of the vitamin A-storing hepatic stellate cells. Perisinusoidal amyloidosis can be the first sign of an underlying B-cell neoplasia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18210108     DOI: 10.1007/s00292-007-0962-2

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  30 in total

1.  Liver disease with periportal sinusoidal dilatation. A possible complication to contraceptive steroids.

Authors:  K Winkler; H Poulsen
Journal:  Scand J Gastroenterol       Date:  1975       Impact factor: 2.423

2.  Intractable ascites in systemic mastocytosis treated by portal diversion.

Authors:  P Bonnet; C Smadja; A M Szekely; Y Delage; Y Calmus; R Poupon; D Franco
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

3.  Phagocytosis of platelets by Kupffer cells in immune thrombocytopenia.

Authors:  J C Neiman; M J Mant; T K Shnitka
Journal:  Arch Pathol Lab Med       Date:  1987-06       Impact factor: 5.534

4.  Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment: a cause of chronic liver disease after kidney transplantation.

Authors:  P G Gerlag; J P van Hooff
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

5.  Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases.

Authors:  H R Makhlouf; K G Ishak; Z D Goodman
Journal:  Cancer       Date:  1999-02-01       Impact factor: 6.860

Review 6.  The hepatic extracellular matrix. I. Components and distribution in normal liver.

Authors:  A Martinez-Hernandez; P S Amenta
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  An epidemic of veno-occlusive disease of liver in central India.

Authors:  B N Tandon; H D Tandon; R K Tandon; M Narndranathan; Y K Joshi
Journal:  Lancet       Date:  1976-08-07       Impact factor: 79.321

8.  Hepatic sinusoidal dilatation related to oral contraceptives. A study of two patients showing ultrastructural changes.

Authors:  M A Spellberg; J Mirro; L Chowdhury
Journal:  Am J Gastroenterol       Date:  1979-09       Impact factor: 10.864

9.  C-Kit (CD117) expression in AIDS-related, classic, and African endemic Kaposi sarcoma.

Authors:  Liron Pantanowitz; Erich J Schwartz; Bruce J Dezube; Sabine Kohler; Ronald F Dorfman; Steven R Tahan
Journal:  Appl Immunohistochem Mol Morphol       Date:  2005-06

Review 10.  Vitamin A hepatotoxicity: a cautionary note regarding 25,000 IU supplements.

Authors:  T E Kowalski; M Falestiny; E Furth; P F Malet
Journal:  Am J Med       Date:  1994-12       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.